Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BAM
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Bad
0%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 4.16 0.83 0.80
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -852.42 -31.25 -3.28
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -76.16 5.65 23.72
Cash -99.89 0.02 20.27
Capex -821.38 -0.10 -0.01
Free Cash Flow -81.97 0.27 -1.51
Revenue -87.73 0.37 2.98
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -4.91 0.94 0.99
Operating Margin -91.08 -0.06 0.63
ROA -17.08 0.03 0.04
ROE -22.03 0.05 0.06
ROIC -97.99 < 0.005 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BAM is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BAM is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BAM is permitted for members.